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Racial-Ethnic Disparities in Acute Stroke Care in the Florida-Puerto
Rico Collaboration to Reduce Stroke Disparities Study
Ralph L. Sacco, MD, MS; Hannah Gardener, ScD; Kefeng Wang, MS; Chuanhui Dong, PhD; Maria A. Ciliberti-Vargas, MPH;
Carolina M. Gutierrez, PhD; Negar Asdaghi, MD; W. Scott Burgin, MD; Olveen Carrasquillo, MD, MPH; Enid J. Garcia-Rivera, MD;
Ulises Nobo, MD; Soﬁa Oluwole, BA; David Z. Rose, MD; Michael F. Waters, MD, PhD; Juan Carlos Zevallos, MD; Mary Robichaux, MPH,
MBA; Salina P. Waddy, MD; Jose G. Romano, MD; Tatjana Rundek, MD, PhD; for the FL-PR CReSD Investigators and Collaborators*

Background-—Racial-ethnic disparities in acute stroke care can contribute to inequality in stroke outcomes. We examined raceethnic disparities in acute stroke performance metrics in a voluntary stroke registry among Florida and Puerto Rico Get With the
Guidelines-Stroke hospitals.
Methods and Results-—Seventy-ﬁve sites in the Florida Puerto Rico Stroke Registry (66 Florida and 9 Puerto Rico) recorded
58 864 ischemic stroke cases (2010–2014). Logistic regression models examined racial-ethnic differences in acute stroke
performance measures and defect-free care (intravenous tissue plasminogen activator treatment, in-hospital antithrombotic
therapy, deep vein thrombosis prophylaxis, discharge antithrombotic therapy, appropriate anticoagulation therapy, statin use,
smoking cessation counseling) and temporal trends. Among ischemic stroke cases, 63% were non-Hispanic white (NHW), 18% were
non-Hispanic black (NHB), 14% were Hispanic living in Florida, and 6% were Hispanic living in Puerto Rico. NHW patients were the
oldest, followed by Hispanics, and NHBs. Defect-free care was greatest among NHBs (81%), followed by NHWs (79%) and Florida
Hispanics (79%), then Puerto Rico Hispanics (57%) (P<0.0001). Puerto Rico Hispanics were less likely than Florida whites to meet
any stroke care performance metric other than anticoagulation. Defect-free care improved for all groups during 2010–2014, but
the disparity in Puerto Rico persisted (2010: NHWs=63%, NHBs=65%, Florida Hispanics=59%, Puerto Rico Hispanics=31%; 2014:
NHWs=93%, NHBs=94%, Florida Hispanics=94%, Puerto Rico Hispanics=63%).

Downloaded from http://ahajournals.org by on May 17, 2022

Conclusions-—Racial-ethnic/geographic disparities were observed for acute stroke care performance metrics. Adoption of a
quality improvement program improved stroke care from 2010 to 2014 in Puerto Rico and all Florida racial-ethnic groups. However,
stroke care quality delivered in Puerto Rico is lower than in Florida. Sustained support of evidence-based acute stroke quality
improvement programs is required to improve stroke care and minimize racial-ethnic disparities, particularly in resource-strained
Puerto Rico. ( J Am Heart Assoc. 2017;6:e004073. DOI: 10.1161/JAHA.116.004073.)
Key Words: cerebrovascular disease • disparities • ethnicity • race

S

troke is the ﬁfth leading cause of death in the United
States, the second leading cause of adult death worldwide, and the main cause of adult disability.1,2 Racial-ethnic
disparities in acute stroke care have been documented in a
statement from the American Heart Association/American
Stroke Association (AHA/ASA),3 and represent a recognized

research priority by the National Institute of Neurological
Disorders and Stroke (NINDS). These disparities can contribute to inequality in outcomes after acute stroke. Disparities exist in stroke mortality, morbidity, prevalence of
biological and environmental risk factors, healthcare access,
and quality of care. Incidence data from NOMAS (the Northern
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Methods
Study Population
In March 2015, the FL-PR Stroke Registry was comprised of
75 hospitals: 66 in FL and 9 in PR. The Registry includes
retrospective and prospective hospital-collected GWTG-S data
on patients with a primary diagnosis of ischemic stroke,
transient ischemic attack, subarachnoid hemorrhage, intracerebral hemorrhage, and stroke not otherwise speciﬁed. In
total, 88 978 cases were enrolled in the FL-PR Stroke
Registry from January 2010 through December 2014, including 58 864 cases with a primary diagnosis of ischemic stroke.
Data were collected for the original purpose of inclusion in the
GWTG-S program––a voluntary, ongoing, national registry with
the goal of improving stroke and cardiovascular disease
care––and additional questions were added for those hospitals participating in the FL-PR Stroke Registry, including
further questions regarding ethnicity, language, education,
and 30-day outcomes. The University of Miami’s institutional
review board approved this study. Each participating center
received institutional ethics approval to enroll cases in the
FL-PR Stroke Registry without requiring individual patient
consent under the common rule or a waiver of authorization
and exemption from subsequent review by their institutional
review board.

DOI: 10.1161/JAHA.116.004073

Data Collection
Healthcare providers in GWTG are trained to utilize patientspeciﬁc guideline information and have immediate access to
clinical decision support through the AHA’s Patient Management Tool, an online, interactive assessment and reporting
system. Stroke patients eligible for the GWTG-S registry are
drawn from those admitted for acute stroke. Trained hospital
personnel screen acute stroke admissions through prospective
clinical identiﬁcation, retrospective identiﬁcation using International Classiﬁcation of Diseases-9th Revision discharge
codes, or a combination. Extracted data include demographics,
mode of arrival, time from symptom onset to hospital arrival,
health insurance information, medical history, brain imaging, inhospital treatment and events (including timing of intravenous
[IV] tissue plasminogen activator [tPA] treatment and contraindications), discharge treatment and counseling, mortality,
and discharge destination. Speciﬁc data on quality performance
measures are collected regarding eligibility for IV recombinant
tPA, stroke onset and arrival times, deep vein thrombosis (DVT)
treatments, dysphagia screening, antithrombotic use, and
statin use. High data quality in the GWTG database is
maintained through careful training for chart abstractors,
standardized coding instructions, limitations of data ﬁelds to
realistic entries, audit trails, and required site data quality
reports. Data on hospital-level characteristics (ie, bed size,
academic status, stroke center certiﬁcation) were obtained
from the Agency for Health Care Administration in FL hospitals
and the American Hospital Registry for Puerto Rico Hospitals, as
well as a self-reported hospital characteristics survey completed by all hospitals participating in the FL-PR Stroke Registry.

Primary Outcome Measures
The stroke care measures of interest are the key performance
indicators essential for improving the quality of care and
outcome of all patients with ischemic stroke: (1) IV tPA
administered to eligible patients who arrived at the hospital
within 2 hours of symptom onset and received treatment
within 3 hours of symptom onset; (2) antithrombotic therapy
by the end of hospital day 2; (3) DVT prophylaxis by the end of
hospital day 2 for nonambulatory patients; (4) discharged on
antithrombotic therapy; (5) appropriate anticoagulation therapy for atrial ﬁbrillation/ﬂutter; (6) discharged on statin
medication for patients with low-density lipoprotein ≥100 or
taking lipid-lowering agents before admission or with unmeasured low-density lipoprotein in the previous 30 days; (7)
counseling or medication for smoking cessation; and (8) the
composite variable of DFC, which is an indicator among those
eligible for a speciﬁc metric of whether all appropriate
interventions listed above in items 1 to 7 are performed
properly.
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Manhattan Study) has demonstrated racial-ethnic differences
in stroke incidence, with blacks and Hispanics having more
than a 2-fold increase in annual stroke incidence compared
with whites.4,5 Some studies have documented disparities in
access to acute stroke care, activation of 911 services,
delayed arrival to the emergency department, longer waiting
times, and treatment delays in thrombolysis.3 The aging and
rapid growth of the Hispanic population and growing socioeconomic crisis in Puerto Rico (PR) may increase the public
health impact of stroke and widen stroke disparities.
The AHA/ASA Get With the Guidelines-Stroke (GWTG-S)
program was developed to improve acute stroke performance
by implementing evidence-based care. National GWTG data
have provided important insights into racial-ethnic disparities
in stroke care, showing poorer acute stroke care in blacks.6
The Florida-Puerto Rico (FL-PR) Stroke Registry is a voluntary
stroke registry consisting of data already collected using the
GWTG-S system as well as additional data (eg, ethnicity,
language, education, 30-day follow-up) among hospitals from
diverse and less investigated US regions. The aims of this
study were to identify racial-ethnic and geographic disparities
in acute stroke performance metrics, overall rates of “defectfree care” (DFC; compliance with all eligible quality metrics),
and evaluate temporal trends in disparities in DFC with a
particular focus on PR.

Racial-Ethnic Disparities in Acute Stroke Care
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We report the frequencies of performance indicators and DFC
for the population of participants with ischemic stroke in the
FL-PR Stroke Registry by race-ethnicity (white, non-Hispanic;
black, non-Hispanic; Hispanic) and geographic region (FL and
PR) overall and across calendar years (2010–2014). NonHispanic white (NHW) was used as the reference group among
those in FL, and PR Hispanics were compared with FL NHWs
and with Hispanics living in FL. To account for the clustering
within hospitals, multilevel logistic regression models were
used when examining racial-ethnic and temporal differences
in stroke performance indicators, with generalized estimating
equations. Multilevel logistic regression was used to examine
whether any observed racial-ethnic disparities persist after
controlling for potential prespeciﬁed explanatory factors.
Model 1 was adjusted for age, model 2 was adjusted for
individual characteristics (age, health insurance status, hospital mode of arrival) and hospital level characteristics (years
in the GWTG-S program, academic hospitals versus not,
number of beds), and model 3 included variables from model
2 with additional adjustments for patient National Institutes of
Health stroke scale (NIHSS) score and vascular risk factors
(current smoker, hypertension, diabetes, dyslipidemia, and
medical history of atrial ﬁbrillation, coronary artery disease/
prior myocardial infarction, previous stroke/transient
ischemic attack). For any covariates with missingness,
missing values of the categorical covariates (including medical
insurance, mode of arrival, and NIHSS score) were imputed
with multiple imputation by discriminant function method
(10 imputations), allowing us to maximize the sample size for
each analysis.
We examined whether racial-ethnic disparities in DFC
changed from 2010 to 2014, controlling for age, sex,
smoking, diabetes, atrial ﬁbrillation, coronary artery disease,
mode of arrival, academic status, number of beds, and years
in the GWTG-S program. Effect modiﬁcation by time was
examined by including interaction terms between year and
race-ethnicity in models.

Results
The study population consisted of 58 864 cases with the
primary diagnosis of acute ischemic stroke (50% women;
63% NHWs living in FL, 18% non-Hispanic blacks [NHBs]
living in FL, 14% Hispanics living in FL, 6% Hispanics living
in PR). Table 1 shows the demographic and clinical
characteristics of the patients overall and stratiﬁed by
race-ethnicity. NHW patients were oldest, followed by
Hispanics, and NHB patients were youngest. Hispanics in
FL and PR were less likely to be current smokers. PR
Hispanics were most likely to have hypertension and

DOI: 10.1161/JAHA.116.004073

diabetes, followed by NHBs, yet PR Hispanics were least
likely to have dyslipidemia. A previous diagnosis of atrial
ﬁbrillation was most prevalent among NHWs and least
prevalent among NHBs and PR Hispanics. Coronary artery
disease or previous myocardial infarction was also observed
less commonly among NHB patients, but was most
prevalent among both NHWs and PR Hispanics. Less than
half of patients arrived by EMS in all groups. NHBs and
Hispanics living in PR were least likely to arrive to the
hospital within 2 hours from symptom onset to be eligible
for IV tPA treatment within 3 hours.
Among the prespeciﬁed acute stroke performance targets,
blacks who smoked were less likely to receive smoking
cessation counseling versus whites (Table 2). In the fully
adjusted models, blacks were more likely to receive VTE
prophylaxis, antithrombotics at discharge, and DFC overall
versus whites. There were no differences in care observed for
Hispanics living in FL versus whites. Covariates predictive of
DFC included male sex, health insurance, arrival by EMS, low
NIHSS score, and dyslipidemia.
PR Hispanics were less likely than whites to receive overall
DFC. PR Hispanics were less likely than FL whites to meet any
of the stroke care performance metrics other than anticoagulation for atrial ﬁbrillation. After adjustment, the disparities
observed for PR Hispanics persisted for early antithrombotics,
antithrombotics at discharge, statin therapy, VTE prophylaxis,
and DFC. Compared with FL Hispanics, PR Hispanics were still
less likely to receive these individual stroke care measures
and DFC (Table 3).
Signiﬁcant effect modiﬁcation by year (2010–2014) was
evident for the association between race-ethnicity and all
stroke care metrics other than smoking cessation counseling. Therefore, Table 4 presents analyses restricted to years
2010 and 2014 for each of the stroke care metrics, as well
as across all 5 years for overall DFC. Within FL, temporal
trends showed improved performance across all stroke care
metrics from 2010 to 2014 for all racial-ethnic subgroups,
other than smoking cessation counseling, which remained
high over time. The percentage of patients receiving DFC
also rose over time (Table 4, Figure). Lower rates of early
antithrombotic use, antithrombotics at discharge, and smoking cessation counseling among blacks compared with
whites in 2010 were no longer disparate by 2014. In
2014, Hispanics living in FL were more likely than whites to
receive IV tPA within 3 hours.
For PR, the rate of DFC improved from 2010 to 2013,
with a slight dip from 2013 to 2014 (Figure). Despite rises in
the absolute rate of DFC among PR Hispanics, in 2012–2014
the rate of DFC was signiﬁcantly lower in PR versus FL
whites and FL Hispanics. In addition, the use of antithrombotics and anticoagulants did not improve in PR from 2010
to 2014.
Journal of the American Heart Association
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Statistical Analysis
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Clinical Characteristics

All
(N=58 864)

FL Non-Hispanic
White
(n=36 844)

FL Non-Hispanic
Black
(n=10 536)

FL Hispanic
(n=8207)

PR Hispanic
(n=3277)

P Value

Age, meanSD, y

70.814.4

72.914.0

63.613.9

70.914.2

70.013.8

<0.0001

Male

50.3

50.5

48.8

51.1

51.9

0.0154

Female

49.7

49.5

51.2

48.9

48.1

Hypertension

65.9

65.4

70.3

55.6

83.4

<0.0001

Diabetes mellitus

28.9

24.8

37.6

27.9

49.6

<0.0001

Dyslipidemia

32.3

41.7

32.4

28.8

24.7

<0.0001

Current smoker

16.8

17.3

19.6

14.2

8.5

<0.0001

Atrial fibrillation

17.4

21.3

8.3

14.8

8.9

<0.0001

Coronary artery disease/prior
myocardial infarction

22.4

24.9

15.5

18.7

25.3

<0.0001

Previous stroke/TIA

25.8

26.0

29.3

21.9

21.5

<0.0001

Sex, %

Vascular risk factor, %

Medical history, %

<0.0001

Medical insurance, %
Private*

36.7

43.1

28.9

20.2

31.0

Medicare

33.0

33.5

30.5

38.5

21.9

Medicaid†

11.5

8.0

23.7

15.5

1.7

Unknown

18.8

15.4

16.9

25.9

45.4
<0.0001

Mode of arrival emergency medical services
Downloaded from http://ahajournals.org by on May 17, 2022

Yes

48.7

52.0

47.6

51.6

47.7

No

44.1

41.0

43.4

37.7

31.6

Missing

7.2

7.0

9.0

10.7

20.6

<2 h

20.3

21.7

15.8

21.7

16.1

<2 to 3.5 h

6.1

6.4

4.8

6.3

7.6

<3.5 to 4.5 h

3.0

3.0

2.7

3.0

2.8

<4.5 to 6 h

3.3

3.4

3.0

3.2

3.1

>6 h

16.5

16.0

16.9

17.4

18.3

50.8

49.5

56.8

48.7

52.1

≤5

36.9

38.6

37.8

32.3

26.8

6 to 15

18.6

18.2

18.9

16.0

28.9

<0.0001

Arrival times

Undocumented/unknown

<0.0001

NIHSS score, %

≥16

11.2

11.5

8.8

10.5

16.8

Missing

33.3

31.7

34.5

41.2

27.5

Hospital characteristics
No. of beds, meanSD

555.6316.5

540.7308.2

641.5330.4

600.8337.1

333.0127.0

<0.0001

Academic hospital

30.8

28.5

33.0

32.3

13.3

<0.0001

Years in GWTG, meanSD

7.92.3

8.22.2

8.12.1

7.22.2

5.51.7

<0.0001

FL indicates Florida; GWTG, Get With the Guidelines; NIHSS, National Institutes of Health Stroke Scale; PR, Puerto Rico; TIA, transient ischemic attack.
*Includes private insurance, Veterans Affairs, and other.
†
Includes Medicaid, self-pay, and no insurance.
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Table 1. Patient and Hospital-Level Characteristics of Patients With Ischemic Stroke in the FL-PR Stroke Registry Cohort, 2010–2014
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Table 2. Acute Stroke Care Metrics Among Different Racial-Ethnic Subgroups in Florida and Puerto Rico, 2010–2014
Florida
AOR (95% CI)

Non-Hispanic White

Puerto Rico
Non-Hispanic Black

Hispanic

Hispanic

IV tPA, arrive by 2 hours and treat by 3 hours
No. eligible

2540

500

552

286

Treated, %

89

87

91

78

Ref

0.96 (0.75–1.22)

1.20 (0.90–1.58)

0.22 (0.07–0.73)

0.92 (0.66–1.28)

1.30 (0.90–1.89)

0.72 (0.24–2.13)

0.89 (0.63–1.26)

1.30 (0.85–2.00)

0.60 (0.21–1.72)

7465

5488

2103

AOR (95% CI) Model 1*
AOR (95% CI) Model 2

†

AOR (95% CI) Model 3‡
Early antithrombotic use
No. eligible

24 813

Treated, %

96

95

96

93

AOR (95% CI) Model 1

Ref

0.91 (0.80–1.03)

0.96 (0.73–1.27)

0.13 (0.05–0.32)

AOR (95% CI) Model 2

0.94 (0.79–1.12)

0.98 (0.69–1.38)

0.37 (0.13–1.06)

AOR (95% CI) Model 3

0.98 (0.84–1.14)

1.01 (0.75–1.36)

0.24 (0.10–0.55)

7654

5621

2095

Antithrombotics at discharge
No. eligible

25 689

Treated, %

98

97

97

94

AOR (95% CI) Model 1

Ref

0.92 (0.77–1.10)

1.04 (0.60–1.80)

0.10 (0.04–0.24)

AOR (95% CI) Model 2

0.97 (0.80–1.18)

1.07 (0.67–1.69)

0.20 (0.09–0.47)

AOR (95% CI) Model 3

1.10 (1.02–1.18)

1.08 (0.96–1.21)

0.29 (0.12–0.74)

Anticoagulation for atrial fibrillation
Downloaded from http://ahajournals.org by on May 17, 2022

No. eligible

4765

601

793

275

Treated, %

96

97

94

90

AOR (95% CI) Model 1

Ref

1.09 (0.76–1.56)

0.93 (0.66–1.33)

0.36 (0.11–1.14)

AOR (95% CI) Model 2

1.07 (0.68–1.68)

0.90 (0.61–1.34)

0.72 (0.26–2.02)

AOR (95% CI) Model 3

1.06 (0.67–1.66)

0.88 (0.59–1.30)

0.67 (0.24–1.85)

Smoking cessation counseling
No. eligible

4712

1524

869

190

Treated, %

97

96

95

93

AOR (95% CI) Model 1

Ref

0.67 (0.55–0.82)

0.86 (0.50–1.46)

0.23 (0.06–0.92)

AOR (95% CI) Model 2

0.69 (0.55–0.86)

0.89 (0.54–1.48)

0.44 (0.12–1.60)

AOR (95% CI) Model 3

0.68 (0.54–0.86)

0.91 (0.54–1.53)

0.44 (0.12–1.61)

LDL ≥100 mg/dL or ND—Statin
No. eligible

19 965

5917

4428

1596

Treated, %

92

93

93

83

AOR (95% CI) Model 1

Ref

1.02 (0.92–1.14)

1.14 (0.86–1.51)

0.15 (0.07–0.31)

AOR (95% CI) Model 2

1.06 (0.96–1.18)

1.16 (0.87–1.54)

0.19 (0.09–0.38)

AOR (95% CI) Model 3

1.10 (0.99–1.22)

1.19 (0.89–1.58)

0.23 (0.12–0.47)

8394

6416

2527

VTE prophylaxis
No. eligible

29 315

Treated, %

85

87

86

67

AOR (95% CI) Model 1

Ref

1.06 (0.99–1.14)

1.05 (0.95–1.16)

0.24 (0.13–0.46)
Continued
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Table 2. Continued
Florida
AOR (95% CI)

AOR (95% CI) Model 2

Non-Hispanic White
§

AOR (95% CI) Model 3

Puerto Rico
Non-Hispanic Black

Hispanic

Hispanic

1.08 (1.00–1.16)

1.07 (0.95–1.20)

0.25 (0.10–0.66)

1.10 (1.02–1.18)

1.08 (0.96–1.21)

0.29 (0.12–0.74)

8538

6529

2588

Defect-free care
No. eligible

29 865

Treated, %

79

81

79

57

AOR (95% CI) Model 1

Ref

1.10 (1.03–1.17)

1.02 (0.96–1.09)

0.35 (0.32–0.38)

AOR (95% CI) Model 2

1.06 (1.00–1.13)

1.05 (0.95–1.16)

0.26 (0.12–0.56)

AOR (95% CI) Model 3

1.07 (1.00–1.14)

1.06 (0.95–1.18)

0.27 (0.12–0.58)

AOR indicates adjusted odds ratio; IV tPA, intravenous tissue plasminogen activator; LDL, low-density lipoprotein; ND, not documented; VTE, venous thromboembolism.
*Model 1 adjusted for age and correlation within and between hospitals.
†
Model 2 additionally adjusted for age, health insurance status, mode of arrival and hospital-level factors including number of beds, years in Get With the Guidelines-Stroke, and academic
vs not.
‡
Model 3 includes variables in model 2 and patient National Institutes of Health Stroke Scale score, current smoker, hypertension, diabetes, dyslipidemia, and medical history of atrial
ﬁbrillation, coronary artery disease/prior myocardial infarction, and previous stroke/transient ischemic attack.
§
In order for this model to converge, health insurance status was not included as a covariate.

Discussion
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In the FL-PR Stroke Registry, racial-ethnic and geographic
disparities were observed in stroke DFC overall and in all
acute stroke care performance metrics other than anticoagulation for atrial ﬁbrillation. These disparities indicated that
whites, blacks, and Hispanics living in FL received superior
stroke care compared with PR Hispanics. PR Hispanics were
less likely to receive DFC compared with FL whites and FL
Hispanics. This was driven by differences in early antithrombotic use and antithrombotic use at discharge, statin therapy,
and VTE prophylaxis. Although stroke care improved over time
in PR, as well as in all racial-ethnic groups in FL from 2010 to
2014, the disparities observed for PR Hispanics compared
with FL whites and FL Hispanics persisted.
It is encouraging to note that DFC was high in the nonwhite populations in FL. DFC was similar in FL Hispanics and
in fact more common among FL blacks as compared with
whites in our registry, even after multivariable adjustment.
Although the difference for blacks reached statistical significance, the absolute difference was quite small (81% in blacks
versus 79% in whites), and therefore the clinical relevance is
limited. The higher rate of DFC among blacks appeared to be
driven by VTE prophylaxis, better low-density lipoprotein
levels/statin therapy, and early antithrombotics. Further
exploration in future studies is warranted.
Stroke care performance for all racial-ethnic groups has
improved during the past 5 years in FL and PR. Although
blacks in FL arrived to the hospital later than whites and were
less likely to receive smoking cessation counseling, they were
more likely to receive overall DFC compared with whites
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among these experienced GWTG-S centers. By 2014 in FL,
racial-ethnic disparities in the major acute stroke performance were minimal to none. However, despite absolute
improvements in DFC over time, disparities in stroke care for
PR Hispanics increased over time relative to NHWs.
As the gap in stroke care between FL and PR widens, the
urgent need for programs and initiatives to improve acute
stroke care grows in the setting of an economic crisis in PR.
PR is undergoing the worst ﬁscal and economic crisis in the
country’s history ($72 billion debt) translating to cutbacks in
medical services, delays in provider payments, and a major
physician exodus leading to deterioration in patient care.7
While 60% of the island’s population receives care through
Medicare or Medicaid, reimbursement rates are 70% lower
compared with that of any other state on the mainland.
Despite the implementation of the AHA GWTG-S program in
15 hospitals in PR, there are shrinking resources to support
the needs of their high-risk population, with only one certiﬁed
primary stroke center. PR is unique in that its population has
declined by 5% during the past decade, with more than
50 000 residents leaving the US territory each year.8 This
exodus, which is expected to continue gradually through
2050, is mainly due to the emigration of younger citizens
secondary to economic decline and has subsequently accelerated the aging of the population.9 In addition, it is estimated
that at least one physician leaves the island each day, which
has detrimental effects on health care, particularly affecting
the aging population. A decade-long recession, exodus of
physicians, and far lower Medicare and Medicaid reimbursements compared with other states have created an economic
and healthcare crisis, which can only lead to further
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PR Hispanic vs FL
Hispanic (Reference)

AOR (95% CI)

IV tPA, arrive by 2 hours and treat by 3 hours
AOR (95% CI) Model 1*
AOR (95% CI) Model 2

†

AOR (95% CI) Model 3‡

0.19 (0.06–0.62)
0.55 (0.18–1.67)
0.46 (0.16–1.38)

Early antithrombotic use
AOR (95% CI) Model 1

0.14 (0.06–0.33)

AOR (95% CI) Model 2

0.37 (0.12–1.14)

AOR (95% CI) Model 3

0.24 (0.10–0.59)

Antithrombotics at discharge
AOR (95% CI) Model 1

0.10 (0.04–0.22)

AOR (95% CI) Model 2

0.19 (0.07–0.49)

AOR (95% CI) Model 3

0.27 (0.11–0.70)

Anticoagulation for atrial fibrillation
AOR (95% CI) Model 1

0.39 (0.12–1.27)

AOR (95% CI) Model 2

0.81 (0.27–2.41)

AOR (95% CI) Model 3

0.76 (0.26–2.26)

Smoking cessation counseling
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AOR (95% CI) Model 1

0.26 (0.06–1.21)

AOR (95% CI) Model 2

0.49 (0.12–2.05)

AOR (95% CI) Model 3

0.49 (0.12–2.07)

LDL ≥100 mg/dL or ND—statin
AOR (95% CI) Model 1

0.13 (0.06–0.28)

AOR (95% CI) Model 2

0.16 (0.08–0.35)

AOR (95% CI) Model 3

0.20 (0.09–0.41)

VTE prophylaxis
AOR (95% CI) Model 1
AOR (95% CI) Model 2

0.23 (0.12–0.44)
§

AOR (95% CI) Model 3

0.24 (0.09–0.62)
0.27 (0.11–0.70)

Defect-free care
AOR (95% CI) Model 1

0.22 (0.12–0.45)

AOR (95% CI) Model 2

0.25 (0.11–0.54)

AOR (95% CI) Model 3

0.25 (0.12–0.55)

AOR indicates adjusted odds ratio; FL, Florida; IV tPA, intravenous tissue plasminogen
activator; LDL, low-density lipoprotein; ND, not documented; PR, Puerto Rico; VTE,
venous thromboembolism.
*Model 1 adjusted for age and correlation within and between hospitals.
†
Model 2 additionally adjusted for age, health insurance status, mode of arrival and
hospital-level factors including number of beds, years in Get With the Guidelines-Stroke,
and academic vs not.
‡
Model 3 includes variables in model 2 and patient National Institutes of Health Stroke
Scale score, current smoker, hypertension, diabetes, dyslipidemia, and medical history of
atrial ﬁbrillation, coronary artery disease/prior myocardial infarction, and previous
stroke/transient ischemic attack.
§
In order for this model to converge, health insurance status was not included as a
covariate.
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disparities in care and outcomes overall. There are also
several hospital-level factors that may contribute to the
inadequate stroke care in PR. Compared with FL hospitals in
the registry, PR hospitals were smaller, had fewer stroke
neurologists, and were less likely to have a stroke unit or
stroke team, were less likely to achieve stroke center
certiﬁcation, and were less likely to have implemented acute
stroke care practices (eg, designated stroke team, stroke care
protocols, and availability of neurological services).
PR faces challenges in delivering the stroke standards of
care required to achieve stroke center designation. Compared
with the United States, PR has less than half the number of
emergency physicians and neurosurgeons.10 PR hospitals also
had a shorter duration of participation in GWTG-S as
compared with FL hospitals overall, and now some PR
hospitals are withdrawing because they lack the staff and
funding to continue data collection. Time in GWTG-S is
associated with increased odds of receiving each predeﬁned
stroke performance measure, although the beneﬁt is not
equally distributed. The greatest rates of improvement were
seen in larger hospitals with more bed capacity, those with
larger annual stroke discharge rates, and those identiﬁed as
teaching hospitals.11
Although not the focus of the current study, the higher
NIHSS score observed among PR Hispanics is noteworthy.
Our data are unable to elucidate whether this is due to
strokes being more clinically severe among PR Hispanics or
whether this is due to delays in hospital arrival, differences in
the familiarity with and recognition of stroke symptoms
among people in PR, or a higher threshold of severity before
patients in PR will seek medical attention at a hospital.
This study was motivated by previous evidence of raceethnic differences in stroke incidence, mortality, and care. The
AHA/ASA summarized the importance of racial-ethnic disparities in stroke care.3 Our study ﬁlls an important gap in stroke
research, as the AHA/ASA emphasized the need for more
statewide or regional stroke registries that track stroke care
data and statistics on quality performance metrics. The
NINDS also recently emphasized their commitment to
supporting much-needed outcomes research that identiﬁes
sources and causes of race/ethnic disparities in the treatment of neurological diseases. This is important for the
transition to a value-based healthcare system in the United
States. This study represents the ﬁrst stroke registry in FL and
PR to focus on racial-ethnic disparities in acute stroke care.
FL and PR are ideal regions for a stroke registry with this
focus. Demographers speculate that FL will have a Hispanic
majority by 2035. However, the current study is not the ﬁrst
regional or statewide stroke registry. The Centers for Disease
Control and Prevention funded 7 state health departments to
implement stroke care improvement registries through the
Paul Coverdell National Acute Stroke Registry.
Journal of the American Heart Association
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Table 4. Acute Stroke Performance Metrics Among Different Racial-Ethnic Groups Over Time, 2010–2014
Percentage, AOR (95% CI)*
FL Non-Hispanic
White

IV tPA, arrive by 2 hours
and treat by 3 hours

FL Non-Hispanic
Black

FL Hispanic

PR Hispanic

Ref

2010

80.0

72.3, 0.59 (0.34–1.02)

85.2, 1.21 (0.66–2.22)

63.9, 1.64 (0.59–4.54)

2014

93.7

96.0, 1.93 (0.93–4.03)

97.0, 2.05 (1.14–3.68)

66.7, 0.24 (0.06–0.90)†

Early antithrombotic use

Ref

2010

95.6

93.0, 0.73 (0.60–0.90)

91.8, 0.85 (0.60–1.19)

94.1, 1.11 (051–2.45)

2014

97.9

97.6, 0.98 (072–1.34)

97.4, 0.96 (0.67–1.38)

84.6, 0.11 (0.06–0.20)†

Antithrombotics at discharge

Ref

2010

96.3

94.7, 0.83 (0.71–0.98)

94.8, 0.85 (0.62–1.15)

94.0, 0.26 (0.08–0.82)†

2014

99.2

99.3, 1.19 (0.64–2.21)

99.1, 0.85 (0.49–1.47)

93.2, 0.20 (0.11–0.39)†

Anticoagulation for atrial fibrillation

Ref

2010

94.0

95.1, 1.42 (0.57–3.58)

90.5, 1.09 (0.46–2.60)

94.4, 1.75 (0.56–5.49)

2014

97.1

96.5, 0.75 (0.33–1.72)

97.8, 1.60 (0.65–3.94)

92.6, 0.72 (0.26–1.94)

98.4

96.9, 0.48 (0.29–0.79)

96.3, 0.75 (0.19–2.88)

95.5, 0.71 (0.18–2.81)

97.9

96.8, 0.70 (0.44–1.12)

96.9, 0.91 (0.38–2.17)

95.2, 0.47 (0.08–2.84)

Smoking cessation counseling
2010
2014
LDL ≥100 mg/dL or ND—Statin

Ref

Ref

2010

87.8

87.9, 0.97 (0.85–1.11)

86.0, 1.03 (0.84–1.26)

78.0, 0.64 (0.23–1.75)

2014

97.3

97.9, 1.22 (0.86–1.73)

98.1, 1.13 (0.73–1.75)

83.4, 0.16 (0.09–0.29)†
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VTE prophylaxis

Ref

2010

70.0

73.2, 0.98 (0.90–1.06)

67.9, 1.08 (0.98–1.20)

34.6, 0.58 (0.12–2.75)

2014

97.3

98.1, 1.11 (0.83–1.48)

98.0, 1.16 (0.83–1.62)

78.7, 0.13 (0.07–0.25)†

Defect-free care

Ref

2010

63.1

65.2, 0.97 (0.89–1.05)

58.7, 1.10 (0.99–1.23)

30.8, 0.69 (0.18–2.73)

2011

67.6

70.9, 1.02 (0.96–1.09)

66.5, 0.96 (0.84–1.09)

39.5, 0.63 (0.16–2.58)

2012

83.4

83.3, 0.99 (0.86–1.14)

84.1, 0.97 (0.80–1.18)

62.8, 0.29 (0.12–0.69)†

2013

91.1

91.7, 1.10 (0.92–1.32)

92.1, 1.12 (0.96–1.30)

76.6, 0.36 (0.19–0.68)†

2014

92.9

93.7, 1.10 (0.90–1.34)

93.5, 1.11 (0.86–1.43)

63.1, 0.13 (0.07–0.25)†

AOR indicates adjusted odds ratio; IV tPA, intravenous tissue plasminogen activator; LDL, low-density lipoprotein; ND, not documented; VTE, venous thromboembolism.
*The model is multilevel adjusted for hospital-level random effect and age, sex, health insurance status, mode of arrival, academic status, number of beds, and years in Get With the
Guidelines.
†
P<0.05 Puerto Rico (PR) Hispanics vs Florida (FL) Hispanics.

Study Strengths
A strength of our study is the use of existing well-established
standardized GWTG-S data. The GWTG-S program includes
data from >3 million stroke admissions from >2600 US
hospitals. Our regional data together with national GWTG-S
data demonstrate that adherence to evidence-based guidelines and quality improvement programs may effectively
minimize and eliminate acute stroke disparities.6 Improved
quality of stroke care over time underscores the importance

DOI: 10.1161/JAHA.116.004073

of prolonged participation in GWTG-S, and differences
observed between FL and PR may be driven in part by the
number of years in GWTG-S. In fact, the dip in DFC in PR in
2014 may be attributable to the addition of new, less
experienced hospitals to the GWTG-S program.
Among a nationwide sample of GWTG-S hospitals evaluated from 2003 to 2008, black patients had less adequate
performance across multiple patient care measures including
receiving IV thrombolysis, DVT prophylaxis, smoking cessation
therapy, discharge antithrombotics, anticoagulants for atrial
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Figure. Defect-free care (DFC) over time across race-ethnicity, 2010–2014. Blue=non-Hispanic white
(NHW); orange=non-Hispanic black (NHB); gray=Florida (FL) Hispanic (H); yellow=Puerto Rico (PR) Hispanic.
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ﬁbrillation, lipid therapy, and of dying in-hospital.12 With the
exception of smoking cessation therapy, these ﬁndings were
not replicated in our study, possibly due to temporal
improvements in acute stroke care among blacks in recent
years. Although overall Hispanic DFC in the national sample
was similar to whites, there was less adequate performance
for antithrombotics and smoking cessation.12 Regional differences were not evaluated in that study. Similar to our
ﬁndings, temporal trends documented signiﬁcantly improved
quality of care in all racial-ethnic subgroups.
Identiﬁcation of disparities is the ﬁrst step in eradicating
them. Our results highlight the need for physician training,
better organization of hospital care resources for acute
stroke, and programs aimed at reducing disparities in stroke
care. Evidence-based quality improvement programs can help
create learning environments for healthcare professionals and
ensure best practices are applied uniformly to all patients and
help eliminate variations in care and disparities.
Our results may not apply to other regions of the United
States. Studies have suggested generalizability of the GWTG
registry overall, but the current study includes a subset of
GWTG-S–participating hospitals in FL and PR and may not
represent stroke care metrics and disparities across raceethnic groups for the entirety of FL and PR. Results comparing
ischemic stroke patients 65 years and older enrolled in GWTGS and Medicare patients with ischemic stroke have generally
shown reasonable comparability.13 GWTG hospitals are more
likely to be larger, urban, teaching centers. Data suggest that
the GWTG-S admissions for Medicare patients older than 65
DOI: 10.1161/JAHA.116.004073

years are generally representative of national samples. FL
centers participating in our FL-PR Stroke Registry had similar
performance results compared with all FL and national GWTG-S
samples. However, the excellent performance of GWTG-S
across multiple stroke measures may not be representative of
non–GWTG-S centers. We restricted our analyses to commonly
collected prespeciﬁed GWTG-S performance metrics. In addition, an important limitation was the high amount of missingness for some covariates, most notably the stroke severity
variable NIHSS score. In order to maintain the sample size and
limit bias, a multiple imputation approach was used.
It is crucial to interpret the results of this study in the
context of the large sample size and many outcomes and
comparisons examined. As mentioned previously, with a very
large sample size, statistically signiﬁcant differences may not
be large enough to be clinically relevant, and the large number
of comparisons increases the opportunity for signiﬁcant
differences observed due to chance alone.
Several studies, led by key FL-PR Stroke Registry collaborators focusing on stroke and cardiovascular disease in PR
have been published in recent years, demonstrating the
burden of stroke in PR and the challenges in acute care.14–16
Most recently (2015), it was shown that stroke was the 5th
leading cause of death and ﬁrst cause of long-term disability in
PR, with ischemic stroke representing 75% of all stroke types
on the island.16 Hypertension and diabetes rates in PR patients
were substantially higher compared with studies that included
national US cohorts. However, our study provides novel insight
into the differences in acute stroke care between FL and PR, as
Journal of the American Heart Association
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Conclusions
Despite temporal improvements in acute stroke care across all
racial-ethnic groups, improvements for Hispanics living in PR
are signiﬁcantly lagging relative to all FL groups. The results
underscore the need for increased healthcare resources in PR
and continued monitoring of disparities in various metrics of
stroke care. Importantly, our ﬁndings highlight the need for
continued investments in evidence-based stroke quality
improvement programs to target areas where performance is
suboptimal and to reduce racial-ethnic disparities.
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we are aware of no other study that has examined this
comparison. It represents the ﬁrst regional stroke registry for
FL and PR, focused on racial-ethnic and geographic disparities
in acute stroke care. Signiﬁcant differences in performance in
some acute stroke care practices were observed between FL
and PR; however, improvements and reductions in disparities
were observed the longer hospitals participated in the hospital
quality improvement GWTG-S program. Speciﬁc interventions
are needed to address smoking cessation counseling among
blacks in FL.

